ArticleOncology letters2023

OCT4‑positive circulating tumor cells may predict a poor prognosis in patients with metastatic castration‑resistant prostate cancer treated with abiraterone plus prednisone therapy.

Yong MaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.